Feeling very humble this morning

Last night I was out on the town – well not really, more like out at Waterston’s in High Street Kensington for the official launch of – The Pill That Steals Lives – a new book by Katinka Blackford Newman.

Of course the book is one thing (and I think you should go and buy a copy) but for me the highlight of the evening was meeting so many people who are campaigning to raise awareness of the problems that anti depressants can cause.

I say problems, but in reality the stories I heard were beyond belief and so very harrowing that I all I could do was to sit there quietly in tears… I urge you to read David Carmichael‘s story. It seems I got away with it. What I went through was nothing compared to what happened to some.

The pain and suffering in the room last night was matched only a sense of quiet anger and frustration. Anger at the drug companies for not stepping up and admitting what’s wrong with their ‘product’ and doing something about it, and frustration that we still don’t have our voices heard above the noise that is generated by the establishment. I was humbled by the great work others have done and continue to do.

And speaking of getting our voices heard – please have a look at AntiDepAware – it’s a great resource that we should all be supporting.

In the UK, the good news is that it looks like GSK want to go court. I for one think this would be a fantastic thing – the chance to bring everything out in the open and re-ignite the whole SSRI debate and put a spotlight on the arguments about what’s wrong with their entire business model – from the way they fix drug trials – to the way they market their drugs – to the suffering they have caused. A trial in the High Court in London will ensure our voices are heard.

I’m ready – bring it on.

 

 

Seroxat Group action – latest news

Great news about the Seroxat Withdrawal Group Litigation in England… we are on our way to trial! AT LAST!!

I’m sure if you read Bob Fiddaman’s blog you know already – see here – but I thought I’d wait until we had passed the time limit for GSK to appeal Mr Justice Foskett’s judgement to proceed with the Seroxat Withdrawal Group Litigation. That time has passed and there was no appeal… we are on our way to trial! AT LAST!!


If you happen to be one of the group claimants and you HAVE NOT received forms from Fortitude Law in the past 2 weeks, then you should contact Fortitude Law via email at lcorr@fortitudelaw.uk or telephone on 0203 667 3775 without delay.


I think I’ll say it again, just because I can … ‘Judgment has been received from the Honourable Mr. Justice Foskett to proceed with the Seroxat Withdrawal Group Litigation’. 

I think there must be quite a few people on the other side who really thought this had gone away, but I can tell them now to look out – it hasn’t gone away and it’s all too real. I’ve said before that, for me, a trial is the only to resolve this issue

The publicity of a High Court hearing will mean the mainstream press  will be free to report on ALL the evidence presented. Now… I’m thinking that this will mean a lot of GSK documents that have until now remained secret will become very public knowledge. You see a case like this, while common in the USA, is unheard of in the UK and the publicity it will generate will be huge. And all those once-secret documents and the information they hold will be available the world over for future claimants to use. I think a whole new raft of claims will be kick-started in the USA alone. I wonder what GSK’s share price will look like after all this? And how institutional investors will view a company that breaks the law and lies & cheats its way to profit?

In the 21st century, ethos & culture – the way a company actually conducts its business – are as important to a PLC as having a blockbuster product to sell. Ethos & culture are intrinsic parts of a modern corporate brand, going way beyond the generic, meaningless mission statement that we see from GSK.

I’d like to finish on a personal note. Perhaps, after all these years, I’m getting nearer to closure. For me, that simply means people will believe what happened to me was real.

More importantly, I hope that Doctors will understand what happened to me was real – and perhaps then we can start to help others who are going through the horrors of withdrawing from Seroxat/Paxil today.

 

 

Why won’t GSK pay compensation in the UK?

I’ve asked this before, but the question is still very relevant – you see, the thing is, GSK has paid out millions in compensation to patients (and their children) in the USA who have been damaged by Seroxat/Paxil – but not a penny in the UK… I’m confused, is GSK admitting Paxil is a dangerous drug in America with the potential for terrible side effects, but saying Seroxat in the UK is completely safe and not dangerous at all?

And there’s me, thinking they were the same pills!

But of course, the answer to the question “Why not pay compensation in the UK as well?” has nothing to do with drug safety or patients’ suffering and everything to do with profits and business.

In the USA cases like this are heard before juries and lawyers will take cases on a ‘no win, no fee’ basis and settlements can be very high, so the drug companies are running scared. Because of this, most cases in the USA are settled out of court and Confidentiality Agreements ensure none of the truth ever comes to light (see below).

However, in the UK, cases are heard before a single High Court Judge, any settlements would be much lower than in America and funding is much harder to find – certainly Legal Aid is no longer an option in 2016.

So in the UK, GSK might use a legal firm, perhaps like Addleshaw Goddard, to obfuscate and ensure litigation drags out for years and years, to the point where many claimants just give up or are scared off or the momentum of the case simply grinds to halt – it’s a war of attrition and has nothing to do with justice or patient safety.

Behind the scenes it seems there are other pressures that can be brought to bear to ensure that big business has a better chance of winning. Business and government are far too close – but more of that on another day.

Certainly,this has been going on far too long in the UK – I wrote this in 2009 (and 2007):  Given the fact that Glaxo is currently on trial in Philadelphia (and will be in the High Court in London next year), [sic] I thought this repost (from March 2007) might of interest to you.

Drug companies usually favour the out of court settlement – they don’t like the public scrutiny that court cases bring – not to mention the previously secret information that all too often comes to light.

But along with the settlement comes the confidentiality ‘agreement’. The message the drug companies send out is “we pay up – you shut up” – while all the while never admitting any blame (for anything).

I’m not sure – are Glaxo admitting they’re settling Paxil (Seroxat) cases in the USA?

Well they are – this download – Glaxo settlement agreement – tells its own story, I guess. Pay particular attention to section 3 – Confidentiality of Settlement…

What I find ironic is that Glaxo, being an English company, is prepared to open its cheque book in America, but not in the UK.

So then, Glaxo:

Why won’t you settle in the UK?

Why won’t you help the thousands of people in the UK who have suffered because of Seroxat?

Haven’t you made enough money from the drug?

Why are we having to slug it out with you in the High Court?

Links to the Philadelphia trial details are herehere and here.

This from Seroxat Sufferers details some of the settlements GSK has made in the USA:

…since 2002 GSK have paid out compensation to victims of Seroxat, including over 3,000 people who became addicted to Seroxat, over 800 women whose children were born with serious heart defects because of Seroxat, and also being found guilty of Seroxat causing, in part, the death of Donald Schell and his family members.

And just to underline how GSK does business here are a few links from a Google search for ‘GSK fines’:

2016…

Happy new year to you all – here’s to a big 2016… and who knows what might happen in the next 12 months!

As ever, this time of the year prompts one to reflect on the past – and also to think about the future – and generally just have a bit of a ramble which is what this is.

I don’t really use Facebook very much but I have seen a group there – Paroxetine Paxil Seroxat Withdrawal – which seems to be a very supportive community and I would suggest you take a look if you haven’t already.

Two things stood out for me while reading the posts on the group’s page.

Firstly, it really is beyond belief that Doctors are STILL prescribing Seroxat/Paxil in 2016. Surely by now, Docs around the world should be aware of all the problems surrounding Seroxat. Glaxo’s manipulation of the drug trials and the way the company hid negative data is no longer a secret – have a look here  and here

Secondly, it seems that healthcare ‘professionals’ have little or no idea how to advise the best way to withdraw from Seroxat. Again, in 2016, there is no excuse for this – neither is there an excuse for any Doctor to deny that patients may well suffer from terrible problems when they try to stop taking Seroxat.

Of course, Glaxo has (in)famously never offered any kind of meaningful withdrawal advice – to do so would be an admission that there is a huge problem with Seroxat… and that would would be bad for business. And we can’t have that, can we?

When I withdrew, I used the 10% rule (and liquid Seroxat) – I never reduced by more than 10% of my current dose and I stabilised for a long time between reductions, waiting until I felt strong enough to try the next reduction. I never put any time limit on the process, rather kept telling myself at least I was moving forward, no matter how slowly. It took me 22 months to stop completely and then a few years

I’ve been writing this blog for quite a while now, so apologies as I’ve just noticed some links in my posts have ‘died’ over the course of the years – I still like to think there’s a lot of good info available here on Seroxat Secrets.

So, deep breath, here we go – it’s another year coming up!

A history of SSRIs

This is a re-post from something I wrote in March 2007 – on reflection, perhaps it should be more accurately entitled A History of SSRIs and the Damage they do to Patients.

I think there may well be a lot of discussion in the coming months about Seroxat dependency and the terrible withdrawal symptoms that many people have to endure as they try to stop taking Seroxat and so I think that the download – A History of SSRIs  is more relevant today than ever.

Looking at my original post, I was remiss as I didn’t credit the author of the download – so belated apologies to Prof David Healy (I think it’s his piece).

Now read on:

Over the years I have collected a few interesting documents and I think it’s just plain selfish to keep them to myself so I’m starting to share them with you.

The one for download here – A History of SSRIs is exactly what it says it is… a history of SSRIs.

You can read about the first SSRI – Zelmid – which was patented in 1972 and made it to market in 1982 before any of the others. I suppose not many of you remember Zelmid though as it was discovered in rare cases to cause a serious neurological disorder called Guillain-Barré Syndrome. This potentially fatal disorder led to the immediate removal of the drug from the market.

But Astra had already begun the development of a derivative of Zelmid, called alaproclate, when Zelmid ran into trouble. Alaproclate was being investigated for both depression and Alzheimer’s disease. But it caused liver problems in one strain of laboratory mice and this was enough to lead Astra to drop it. Shortly after this, Astra introduced an innovative antipsychotic, remoxipride, which looked like it would have significantly fewer side effects than older agents. Several months after its launch, however, remoxipride was reported to cause aplastic anemia in a small number of people and it too was withdrawn.

Notice a pattern here?

And did you know this about Prozac? As Eli Lilly were trying to launch Prozac in Germany they came up against a slight problem with the view of the German regulators on fluoxetine (Prozac) as of May 1984: “Considering the benefit and the risk, we think this preparation totally unsuitable for the treatment of depression”.

A History of SSRIs is an enlightening document – with a large section on Seroxat…

 

 

What I believe

I believe Seroxat is defective and dangerous.

I believe that Glaxo has hidden clinical trial data that shows exactly how dangerous a drug it is.

I believe that Seroxat is addictive.

I believe that Seroxat can cause anger, aggression and violence.

I believe that something must be done to help people who suffer terrible problems with withdrawal, as they desperately try to stop taking Seroxat.

I believe that doctors have taken large sums of money from Glaxo to lie about the efficacy and safety of the drug.

I believe that GlaxoSmithKline puts profits before patients – their wealth before our health.

I took Seroxat for 9 years and it took me 22 months to withdraw from the drug little by little.

Believe me – I know what I’m talking about.

RxISK – Making medicines safer for all of us

This is good.

Here’s a new website that Prof David Healy’s involved with. RxISK is a free, independent drug safety website where you can research a prescription drug to see what side effects have been reported and also share your experience and get a free RxISK Report to take to your doctor if need be.

This from RxISK:

A Good Drug is a chemical + Good Information. Most of the information on what drugs actually do is missing. Only you can provide it. Using RxISK will tell you more about the drugs you are prescribed than anything else will. By reporting to RxISK you can help make Good Drugs. Less than 5% of drug side effects are reported. Your voice has been silenced – globally.

Little is known about the effects of drugs on our hair, sex and relationships, violent and other extreme acts or thoughts, and our skin and nails, because these effects are not considered medically significant and are not tracked.

We have created the RxISK Zones with two purposes in mind:

  1. To enable you to easily search for prescription drug side effects on hair, sex, violence, suicide, and other aspects of our every day lives in the more than three million adverse drug event reports filed with the FDA since 2004, as well as our expanding RxISK database.
  2. To make it even easier for you to report these types of prescription drug side effects on RxISK.org and with your country’s drug regulator or the FDA if we don’t yet have your country’s form.

Just imagine — by reporting your experiences, you can help make RxISK the most comprehensive source of independent information on drug side effects in these important personal areas.

How it works

At the bottom of any Zone page, simply enter a prescription drug and click Continue. On the following summary page, check the box next to any side effect you are experiencing, and click the Report a drug side effect button to quickly create your personalized RxISK Report with your RxISK Score to take to your health care professional to help them help you.

The page is here if you want to add to the real world knowledge available about the drugs you take.

%d bloggers like this: